James L. McManaman, et.al., Perilipin-2-null mice are protected against diet-induced obesity, adipose inflammation, and fatty liver disease., Journal of lipid research, 2013, 54

http://rdf.ncbi.nlm.nih.gov/pubmed/23402988

James L. McManaman, et.al., Perilipin-2-null mice are protected against diet-induced obesity, adipose inflammation, and fatty liver disease., Journal of lipid research, 2013, 54

pubmed

allele

http://purl.org/net/cito/citesAsAuthority

• Plin2<tm1.1Asg>
  http://metadb.riken.jp/db/mgi_rdf/MGI:5502311

class

http://purl.org/net/cito/citesAsAuthority

• Plin2<tm1.1Asg>
  http://metadb.riken.jp/db/mgi_rdf/MGI:5502311

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• decreased body weight_Plin2<tm1.1Asg>/Plin2<tm1.1Asg>
  http://metadb.riken.jp/0001262B6129S2CgPlin2tm11AsgPlin2tm11AsgPlin2tm11AsgPlin2tm11Asg
• hyperactivity_Plin2<tm1.1Asg>/Plin2<tm1.1Asg>
  http://metadb.riken.jp/0001399B6129S2CgPlin2tm11AsgPlin2tm11AsgPlin2tm11AsgPlin2tm11Asg
• decreased inflammatory response_Plin2<tm1.1Asg>/Plin2<tm1.1Asg>
  http://metadb.riken.jp/0001876B6129S2CgPlin2tm11AsgPlin2tm11AsgPlin2tm11AsgPlin2tm11Asg
• decreased susceptibility to hepatic steatosis_Plin2<tm1.1Asg>/Plin2<tm1.1Asg>
  http://metadb.riken.jp/0002310B6129S2CgPlin2tm11AsgPlin2tm11AsgPlin2tm11AsgPlin2tm11Asg
• decreased circulating triglyceride level_Plin2<tm1.1Asg>/Plin2<tm1.1Asg>
  http://metadb.riken.jp/0002644B6129S2CgPlin2tm11AsgPlin2tm11AsgPlin2tm11AsgPlin2tm11Asg
• decreased circulating free fatty acid level_Plin2<tm1.1Asg>/Plin2<tm1.1Asg>
  http://metadb.riken.jp/0002702B6129S2CgPlin2tm11AsgPlin2tm11AsgPlin2tm11AsgPlin2tm11Asg
他11件を見る
• decreased susceptibility to diet-induced obesity_Plin2<tm1.1Asg>/Plin2<tm1.1Asg>
  http://metadb.riken.jp/0005659B6129S2CgPlin2tm11AsgPlin2tm11AsgPlin2tm11AsgPlin2tm11Asg
• abnormal adipose tissue physiology_Plin2<tm1.1Asg>/Plin2<tm1.1Asg>
  http://metadb.riken.jp/0005666B6129S2CgPlin2tm11AsgPlin2tm11AsgPlin2tm11AsgPlin2tm11Asg
• decreased circulating leptin level_Plin2<tm1.1Asg>/Plin2<tm1.1Asg>
  http://metadb.riken.jp/0005668B6129S2CgPlin2tm11AsgPlin2tm11AsgPlin2tm11AsgPlin2tm11Asg
• abnormal maternal behavior_Plin2<tm1.1Asg>/Plin2<tm1.1Asg>
  http://metadb.riken.jp/0008779B6129S2CgPlin2tm11AsgPlin2tm11AsgPlin2tm11AsgPlin2tm11Asg
• decreased subcutaneous adipose tissue amount_Plin2<tm1.1Asg>/Plin2<tm1.1Asg>
  http://metadb.riken.jp/0008844B6129S2CgPlin2tm11AsgPlin2tm11AsgPlin2tm11AsgPlin2tm11Asg
• abnormal white fat cell morphology_Plin2<tm1.1Asg>/Plin2<tm1.1Asg>
  http://metadb.riken.jp/0009117B6129S2CgPlin2tm11AsgPlin2tm11AsgPlin2tm11AsgPlin2tm11Asg
• decreased fat cell size_Plin2<tm1.1Asg>/Plin2<tm1.1Asg>
  http://metadb.riken.jp/0009269B6129S2CgPlin2tm11AsgPlin2tm11AsgPlin2tm11AsgPlin2tm11Asg
• decreased epididymal fat pad weight_Plin2<tm1.1Asg>/Plin2<tm1.1Asg>
  http://metadb.riken.jp/0009289B6129S2CgPlin2tm11AsgPlin2tm11AsgPlin2tm11AsgPlin2tm11Asg
• decreased liver triglyceride level_Plin2<tm1.1Asg>/Plin2<tm1.1Asg>
  http://metadb.riken.jp/0009356B6129S2CgPlin2tm11AsgPlin2tm11AsgPlin2tm11AsgPlin2tm11Asg
• decreased total body fat amount_Plin2<tm1.1Asg>/Plin2<tm1.1Asg>
  http://metadb.riken.jp/0010025B6129S2CgPlin2tm11AsgPlin2tm11AsgPlin2tm11AsgPlin2tm11Asg
• decreased food intake_Plin2<tm1.1Asg>/Plin2<tm1.1Asg>
  http://metadb.riken.jp/0011940B6129S2CgPlin2tm11AsgPlin2tm11AsgPlin2tm11AsgPlin2tm11Asg